1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pretreatment eosinophil counts (PEC) in metastatic urothelial carcinoma (mUC) treated with anti-PD1/PD-L1 checkpoint inhibitors (CPI)
    Meeting Abstract

    Mota, J. M.; Teo, M. Y.; Whiting, K.; Ostrovnaya, I.; Li, H.; Lee, C. H.; Funt, S. A.; Callahan, M. K.; Iyer, G.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Heller, G.; Bryce, A. H.; Armstrong, A. J.; Beltran, H.; Hahn, O. M.; McGary, E. C.; Mehan, P. T.; Goldkorn, A.; Roth, B. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ill, multicenter study to assess the diagnostic performance and clinical impact of (18)F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR)
    Meeting Abstract

    Morris, M. J.; Pouliot, F.; Saperstein, L.; Rowe, S. P.; Gorin, M. A.; Josephson, D. Y.; Wong, J. Y. C.; Carroll, P.; Lin, T.; Stambler, N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Early results from the BRCA Founder Outreach (BFOR) Study: Population genetic screening using a medical model
    Meeting Abstract

    Morgan, K.; Gabriel, C.; Symecko, H.; Lester, J.; Levin, J.; Kamara, D.; Spielman, K.; Jenkins, C.; Hamilton, J. G.; Fesko, Y. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study
    Meeting Abstract

    Mora, J.; Kushner, B. H.; Flores, M. A.; Santa-Maria, V.; Garraus, M.; Basu, E. M.; Roberts, S. S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pharmacodynamic effect of IMCgp100 (TCR-CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanoma
    Meeting Abstract

    Middleton, M. R.; Steven, N. M.; Evans, T. R. J.; Infante, J. R.; Hamid, O.; Shoushtari, A. N.; Corrie, P. G.; Anthoney, A.; Gupta, A.; Woodcock, V. K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase III, multicenter, randomized, open label trial of [fam-] trastuzumab deruxtecan (DS-8201a) versus investigator's choice in HER2-low breast cancer
    Meeting Abstract

    Modi, S.; Ohtani, S.; Lee, C. C.; Wang, K.; Saxena, K.; Cameron, D. A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study
    Meeting Abstract

    Moore, K. N.; Chambers, S. K.; Hamilton, E. P.; Chen, L. M.; Oza, A. M.; Ghamande, S. A.; Konecny, G. E.; Plaxe, S. C.; Spitz, D. L.; Geenen, J. J. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Breast radiotherapy among ATM-mutation carriers
    Meeting Abstract

    Modlin, L. A.; Flynn, J.; Zhang, Z.; Mueller, B.; Khan, A. J.; Gillespie, E. F.; Cahlon, O.; McCormick, B.; Robson, M. E.; Powell, S. N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save